The goal of this clinical trial is to learn if transcranial magnetic stimulation(rTMS) can improve neurological rehabilitation in patients with acute ischemic stroke. The main questions it aims to answer are: Can rTMS Promote Recovery of Limb Impairment in Patients with Acute Ischemia? Can rTMS Cause Changes in the Functional Connections of Brain Networks in Patients? Researchers will compare rTMS therapy to non-stimulation therapy to see if rTMS is effective in promoting neurological recovery from ischemic stroke. Participants will: Receive rTMS or sham stimulation with LF-rTMS on the contralateral M1 of the brain lesion for 20 minutes, 1200 pulses, 120% RMT, and a treatment period of 5 days; Be evaluated on a scale before and after treatment
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
40
LF-rTMS of M1 contralateral to the brain lesion for 20 min, 1200 pulses, 120% RMT, treatment cycle of 5 days
Jiangsu Provincial People's Hospital
Nanjing, Jiangsu, China
Improvement in patient motor function
Fugl-Meyer assessment scale,FMA Score: Minimum: 0 points, Maximum: 100 points The higher the score, the better the limb function.
Time frame: Before patient treatment and 5 days after patient treatment
Altered functional connectivity of brain networks in patients
data from near-infrared functional brain imaging acquisitions
Time frame: Patient before and after treatment on the first and fifth day of treatment and during rTMS treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.